Iron chelators: all 144 studies that test it

Page 2 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron OverloadCompletedNCT01369719Not applicable
• Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human EndotoxemiaCompletedNCT01349699Not applicable
• Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron OverloadCompletedNCT01335035Phase 4
• Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea TardaStatus unknownNCT01284946Phase 2
• The Impact of Deferasirox on Non-Alcoholic-SteatohepatitisCompletedNCT01278056Phase 1/2
• This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.CompletedNCT01250951Phase 4
• A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe ToxicityCompletedNCT01044186Phase 2
• Chromium's Effect on Insulin Resistance in ObesityCompletedNCT00997659Not applicable
• Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's DiseaseCompletedNCT00943748Phase 2/3
• Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)Status unknownNCT00907283Phase 2
• Binge Eating and Chromium StudyCompletedNCT00904306Phase 1/2
• A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's AtaxiaCompletedNCT00897221Phase 2
• Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 MsecCompletedNCT00879242Phase 2
• Iron Balance Study of Deferasirox, Deferoxamine and the Combination of BothStatus unknownNCT00738413Phase 1/2
• Efficacy Study of the Use of Sequential DFP-DFO Versus DFPCompletedNCT00733811Phase 4
• Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadCompletedNCT00673608Phase 4
• Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron OverloadCompletedNCT00654589Phase 4
• Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron OverloadCompletedNCT00564941Phase 4
• Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron OverloadCompletedNCT00560820Phase 1
• A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's AtaxiaCompletedNCT00530127Phase 1/2
• Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron OverloadCompletedNCT00481143Phase 4
• Effects of Chromium Picolinate on Food IntakeCompletedNCT00477854Not applicable
• Safety, Tolerability, and Efficacy of Deferasirox in MDSCompletedNCT00469560Phase 3
• Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over LoadCompletedNCT00452660Phase 4
• Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.CompletedNCT00432627Phase 1
• Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of MidazolamCompletedNCT00427505Phase 1
• Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy VolunteersCompletedNCT00419172Phase 1
• Iron-fortified Whole Maize Flour TrialCompletedNCT00386074Phase 2
• Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron OverloadCompletedNCT00379483Phase 2
• Study With Deferiprone and/or Desferrioxamine in Iron Overloaded PatientsCompletedNCT00350662Phase 3
• Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent PatientsCompletedNCT00349453Phase 2
• Pilot Trial of Chromium-Metformin Combination in Type 2 DiabetesTerminatedNCT00332085Phase 1
• A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DMCompletedNCT00308451Not applicable
• Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DMCompletedNCT00289354Not applicable
• Chromium and Insulin ActionCompletedNCT00283777Phase 4
• A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron OverloadCompletedNCT00171821Phase 3
• A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional HemosiderosisCompletedNCT00171171Phase 3
• Chromium Picolinate for the Treatment of Metabolic SyndromeCompletedNCT00128154Not applicable
• Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected AdultsCompletedNCT00109746Phase 1/2
• Efficacy Study in Removing Excess Iron From the HeartCompletedNCT00105495Phase 4
• Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia MajorStatus unknownNCT00103753Phase 4
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00067080Phase 2
• Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
• Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00061750Phase 3

← Iron chelators overview